CareDx Financial Statements (CDNA)
|
|
|
|
Report date
|
|
|
24.02.2022 |
27.02.2023 |
31.12.2023 |
28.02.2025 |
25.02.2026 |
|
28.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
296.4 |
321.8 |
280.3 |
333.8 |
379.8 |
|
412.8 |
|
Operating Income, bln rub |
|
|
-29.7 |
-77.2 |
-203.4 |
40.8 |
-21.0 |
|
-13.2 |
|
EBITDA, bln rub |
? |
|
-17.8 |
-61.2 |
-84.9 |
-34.0 |
-0.667 |
|
10.1 |
|
Net profit, bln rub |
? |
|
-30.7 |
-76.6 |
-190.3 |
52.5 |
-21.4 |
|
-8.19 |
|
|
OCF, bln rub |
? |
|
-19.3 |
-25.2 |
-18.4 |
38.0 |
42.0 |
|
72.9 |
|
CAPEX, bln rub |
? |
|
20.3 |
24.3 |
9.24 |
6.48 |
5.91 |
|
7.76 |
|
FCF, bln rub |
? |
|
-39.6 |
-49.6 |
-27.6 |
31.6 |
36.1 |
|
65.2 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
228.7 |
286.8 |
381.7 |
183.4 |
275.4 |
|
296.2 |
|
Cost of production, bln rub |
|
|
97.4 |
112.2 |
102.0 |
109.6 |
125.4 |
|
129.8 |
|
R&D, bln rub |
|
|
76.5 |
90.4 |
81.9 |
72.4 |
71.4 |
|
74.3 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
566.6 |
543.0 |
466.8 |
491.1 |
413.2 |
|
411.1 |
|
Net Assets, bln rub |
? |
|
465.9 |
430.9 |
261.3 |
378.4 |
303.1 |
|
313.5 |
|
Debt, bln rub |
|
|
21.4 |
39.0 |
34.2 |
28.4 |
19.7 |
|
17.8 |
|
Cash, bln rub |
|
|
348.5 |
293.1 |
235.4 |
260.7 |
177.2 |
|
187.2 |
|
Net debt, bln rub |
|
|
-327.1 |
-254.1 |
-201.2 |
-232.3 |
-157.5 |
|
-169.3 |
|
|
Ordinary share price, rub |
|
|
45.5 |
11.4 |
12.0 |
21.4 |
18.8 |
|
5.96 |
|
Number of ordinary shares, mln |
|
|
52.2 |
53.3 |
53.8 |
52.8 |
53.3 |
|
51.2 |
|
|
Market cap, bln rub |
|
|
2 376 |
608 |
645 |
1 130 |
1 004 |
|
305 |
|
EV, bln rub |
? |
|
2 049 |
354 |
444 |
898 |
846 |
|
136 |
|
Book value, bln rub |
|
|
379 |
350 |
175 |
300 |
231 |
|
241 |
|
|
EPS, rub |
? |
|
-0.59 |
-1.44 |
-3.54 |
1.00 |
-0.40 |
|
-0.16 |
|
FCF/share, rub |
|
|
-0.76 |
-0.93 |
-0.51 |
0.60 |
0.68 |
|
1.27 |
|
BV/share, rub |
|
|
7.25 |
6.57 |
3.26 |
5.68 |
4.33 |
|
4.71 |
|
|
EBITDA margin, % |
? |
|
-6.02% |
-19.0% |
-30.3% |
-10.2% |
-0.18% |
|
2.44% |
|
Net margin, % |
? |
|
-10.3% |
-23.8% |
-67.9% |
15.7% |
-5.62% |
|
-1.98% |
|
FCF yield, % |
? |
|
-1.66% |
-8.15% |
-4.28% |
2.79% |
3.60% |
|
21.4% |
|
ROE, % |
? |
|
-6.58% |
-17.8% |
-72.8% |
13.9% |
-7.05% |
|
-2.61% |
|
ROA, % |
? |
|
-5.41% |
-14.1% |
-40.8% |
10.7% |
-5.17% |
|
-1.99% |
|
|
P/E |
? |
|
-77.5 |
-7.94 |
-3.39 |
21.5 |
-47.0 |
|
-37.2 |
|
P/FCF |
|
|
-60.1 |
-12.3 |
-23.4 |
35.8 |
27.8 |
|
4.68 |
|
P/S |
? |
|
8.02 |
1.89 |
2.30 |
3.39 |
2.64 |
|
0.74 |
|
P/BV |
? |
|
6.27 |
1.74 |
3.68 |
3.77 |
4.35 |
|
1.26 |
|
EV/EBITDA |
? |
|
-114.8 |
-5.79 |
-5.23 |
-26.4 |
-1 269 |
|
13.5 |
|
Debt/EBITDA |
|
|
18.3 |
4.15 |
2.37 |
6.83 |
236.2 |
|
-16.8 |
|
|
R&D/CAPEX, % |
|
|
377.7% |
371.4% |
886.0% |
1 117% |
1 208% |
|
957.6% |
|
|
CAPEX/Revenue, % |
|
|
6.84% |
7.56% |
3.30% |
1.94% |
1.56% |
|
1.88% |
|
| CareDx shareholders |
